0000874716-24-000039.txt : 20240216
0000874716-24-000039.hdr.sgml : 20240216
20240216175644
ACCESSION NUMBER: 0000874716-24-000039
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240214
FILED AS OF DATE: 20240216
DATE AS OF CHANGE: 20240216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MAZELSKY JONATHAN JAY
CENTRAL INDEX KEY: 0001556270
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19271
FILM NUMBER: 24649859
MAIL ADDRESS:
STREET 1: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092
FORMER NAME:
FORMER CONFORMED NAME: MAZELSKY JAY
DATE OF NAME CHANGE: 20120815
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE
CENTRAL INDEX KEY: 0000874716
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 010393723
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092-2041
BUSINESS PHONE: 2075560300
MAIL ADDRESS:
STREET 1: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092-2041
FORMER COMPANY:
FORMER CONFORMED NAME: IDEXX CORP / DE
DATE OF NAME CHANGE: 19600201
4
1
wk-form4_1708124192.xml
FORM 4
X0508
4
2024-02-14
0
0000874716
IDEXX LABORATORIES INC /DE
IDXX
0001556270
MAZELSKY JONATHAN JAY
ONE IDEXX DRIVE
WESTBROOK
ME
04092
1
1
0
0
President and CEO
0
Common Stock
2024-02-14
4
M
0
435
0
A
79681.5926
D
Common Stock
2024-02-14
4
M
0
974
0
A
80655.5926
D
Common Stock
2024-02-14
4
M
0
689
0
A
81344.5926
D
Common Stock
2024-02-14
4
M
0
958
0
A
82302.5926
D
Common Stock
2024-02-14
4
M
0
1100
0
A
83402.5926
D
Common Stock
2024-02-14
4
F
0
1839
560.56
D
81563.5926
D
Non-Qualified Stock Option (right-to-buy)
560.56
2024-02-14
4
A
0
21335
0
A
2034-02-13
Common Stock
21335
21335
D
Incentive Stock Option (right-to-buy)
560.56
2024-02-14
4
A
0
178
0
A
2034-02-13
Common Stock
178
178
D
Restricted Stock Unit
2024-02-14
4
M
0
435
0
D
Common Stock
435
0
D
Restricted Stock Unit
2024-02-14
4
M
0
974
0
D
Common Stock
974
0
D
Restricted Stock Unit
2024-02-14
4
M
0
689
0
D
Common Stock
689
689
D
Restricted Stock Unit
2024-02-14
4
M
0
958
0
D
Common Stock
958
1916
D
Restricted Stock Unit
2024-02-14
4
M
0
1100
0
D
Common Stock
1100
3298
D
Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2025.
Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2028.
Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2020.
Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in four annual installments, beginning February 14, 2021.
Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022.
Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023.
Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2024.
/s/ Lily J. Lu, Attorney-in-Fact for Jonathan Jay Mazelsky
2024-02-16